Wolfe Research lowers Honeywell stock price target on aerospace weakness

The near-term setup is less about the headline earnings miss and more about a forced reset in expectations into a structural break-up. When a company is simultaneously absorbing stranded costs, issuing debt, and recasting guidance around a spin, reported margins become noisy enough that consensus typically over-penalizes the first 1-2 quarters and then has to re-rate once the cleaner post-spin earnings base becomes visible. That creates a tactical dislocation: the stock can stay weak even if underlying operations are stabilizing, because the market is pricing the accounting drag as if it were a permanent deterioration.

The bigger second-order issue is the aerospace bottleneck. If backlog is strong but production is constrained, the value capture shifts downstream to suppliers with actual capacity and away from the prime contractor until the line-rate inflects. That means HON’s own recovery may lag the broader aerospace cycle by multiple quarters, while peers with cleaner execution and less restructuring noise can keep compounding; the market will likely reward visible conversion of backlog into shipments more than backlog growth itself.

The Middle East cost hit matters most as a margin variability signal, not just a one-off dollar amount. It increases the probability that investors will assign a lower multiple to the Process and Automation mix until there is evidence the shock is transitory and not a recurring surcharge embedded in procurement or logistics. The key contrarian point is that the stock may already be discounting a worse long-run aerospace margin profile than is warranted; if production ramps into year-end and the spin removes the accounting overhang, the valuation gap could close faster than the street expects.